Vera Therapeutics (NASDAQ:VERA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Vera Therapeutics Stock (NASDAQ: VERA) stock price, news, charts, stock research, profile.

Open	$46.47
Close	-
Volume / Avg.	4.92K / 745.42K
Day Range	$46.47 - $46.58
52 Wk Range	12.28 - 51.61
Market Cap	$2.92B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	13.46%
Days to Cover	5.61

Recent News

Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney Function For Patients At Almost Two Years

Vera Therapeutics announces ORIGIN Phase 2b trial data on atacicept, showing sustained IgAN improvement and kidney function stability over 96 weeks.

Vandana Singh

PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Vaxcyte, Shoals Technologies, Polestar Automotive, Applied Optoelectronics And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$46.47
Close	-
Volume / Avg.	4.92K / 745.42K
Day Range	$46.47 - $46.58
52 Wk Range	12.28 - 51.61
Market Cap	$2.92B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	53
Short Interest	13.46%
Days to Cover	5.61

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vera Therapeutics (VERA) stock?

You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.

View our list of the best stock brokerages

Who are Vera Therapeutics (VERA) competitors?

Other companies in Vera Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), MoonLake (NASDAQ:MLTX), SpringWorks Therapeutics (NASDAQ:SWTX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).

What is the forecast, or price target, for Vera Therapeutics (VERA) stock?

Vera Therapeutics has a consensus price target of $51.36.

What is the current price for Vera Therapeutics (VERA)?

The stock price for Vera Therapeutics (NASDAQ: VERA) is $46.1 last updated November 26, 2024 at 9:30 AM EST.

Does Vera Therapeutics (VERA) pay a dividend?

A quarterly cash dividend of 0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.

When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?

Vera Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Vera Therapeutics (VERA) going to split?

There is no upcoming split for Vera Therapeutics.

What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Vera Therapeutics

Vera Therapeutics (VERA) Forecast